Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Disease free survival"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 16810
Tytuł:
Impact of preoperative white blood cell count on outcomes in different stage colorectal cancer patients undergoing surgical resection: a single-institution retrospective cohort study.
Autorzy:
Wang B; Department of Anesthesiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China.
Ling D; Department of Anesthesiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China.
Li L; Department of Anesthesiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China.
Zhang J; Department of Anesthesiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China.
Xu J; Department of Anesthesiology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China. .; Department of Oncology, Shanghai Medical College, Fudan University, 200032, Shanghai, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 21; Vol. 24 (1), pp. 242. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/surgery
Leukopenia*
Humans ; Retrospective Studies ; Prognosis ; Leukocyte Count ; Disease-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of hepatic inflammation and fibrosis on the recurrence and long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after hepatectomy.
Autorzy:
Hao X; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, 610041, Chengdu, China.; Department of General Surgery, Gansu Provincial Hospital, 730000, Lanzhou, China.
Xu L; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, 610041, Chengdu, China.
Lan X; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, 610041, Chengdu, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Chongqing Medical University, 400016, Chongqing, China.
Li B; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, 610041, Chengdu, China.
Cai H; Department of General Surgery, Gansu Provincial Hospital, 730000, Lanzhou, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 15; Vol. 24 (1), pp. 475. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Hepatitis B*/complications
Hepatitis B, Chronic*/complications
Humans ; Hepatitis B virus/genetics ; Hepatectomy/adverse effects ; Hepatectomy/methods ; Hepatitis B e Antigens ; Disease-Free Survival ; Retrospective Studies ; Liver Cirrhosis/complications ; Liver Cirrhosis/surgery ; Inflammation/complications
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer.
Autorzy:
Chen H; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Wang C; Department of Pathology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.
Chen Z; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Huang T; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Lin Y; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Chen J; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Zhang B; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China. .; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China. .; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China. .
He X; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China. .; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China. .; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 433. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Peripheral Nerves*/pathology
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/surgery
Humans ; Prognosis ; Retrospective Studies ; Disease-Free Survival ; Neoplasm Invasiveness/pathology ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial.
Autorzy:
Wang X; Department of General Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.
Lu C; Department of General Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.
Wei B; Department of General Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.
Li S; Department of General Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.
Li Z; Department of Gastrointestinal Surgery, Peking University Cancer Hospital, No. 52 Fucheng Road, Haidian District, Beijing, 100142, China.
Xue Y; Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, 150081, China.
Ye Y; Department of Gastroenterological Surgery, Peking University People's Hospital, No.11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Zhang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, No.95 Yongan Road, Xicheng District, Beijing, 100050, China.
Sun Y; Department of General Surgery, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China.
Liang H; Department of Gastric Cancer Surgery, Tianjin Medical University Cancer Hospital, West Huan-Hu Road, Ti Yuan Bei, Hexi District, Tianjin, 300060, China.
Li K; Department of Surgical Oncology, The First Hospital of China Medical University, No.155 Nanjing Street North, Heping District, Shenyang, Liaoning Province, 110002, China.
Zhu L; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No.3 East Qingchun Road, Shangcheng District, Hangzhou, Zhejiang Province, 310016, China.
Zheng Z; Department of Gastric Surgery, Liaoning Cancer Hospital and Institute, No.44 Xiaoheyan Road, Dadong District, Shenyang, Liaoning Province, 110042, China.
Zhou Y; Department of General Surgery, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Shinan District, Qingdao, Shandong Province, 266000, China.
He Y; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, No.58 Zhongshaner Road, Guangzhou, Guangdong Province, 510080, China.
Li F; Department of General Surgery, Xuanwu Hospital, Capital Medical University, No.45 Changchun Street, Xicheng District, Beijing, 100053, China.
Wang X; Department of General Surgery, Peking University First Hospital, No.8 Xishiku Street, Xicheng District, Beijing, 100034, China.
Liang P; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dalian Medical University, No.222 Zhongshan Road, Xigang District, Dalian, Liaoning Province, 116011, China.
Huang H; Department of Gastric Surgery, Fudan University Shanghai Cancer Center, No. 270 Dongan Road, Xuhui District, Shanghai, 200032, China.
Li G; Institute of General Surgery, General Hospital of Eastern Theater Command of Chinese PLA, No.305 East Zhongshan Road, Xuanwu District, Nanjing, Jiangsu Province, 210002, China.
Shen X; Division of Gastrointestinal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, No.109 West Xueyuan Road, Wenzhou, Zhejiang Province, 325027, China.
Ji J; Department of Gastrointestinal Surgery, Peking University Cancer Hospital, No. 52 Fucheng Road, Haidian District, Beijing, 100142, China.
Tang Y; Department of General Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.
Xu Z; Department of General Surgery, Jiangsu Province Hospital, No.300 Guangzhou Road, Gulou District, Nanjing, Jiangsu Province, 210029, China.
Chen L; Department of General Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China. .; Department of Gastrointestinal Surgery, Peking University International Hospital, No.1 Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing, 102206, China. .
Pokaż więcej
Corporate Authors:
RESONANCE study group
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2024 Apr 08; Vol. 17 (1), pp. 17. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Letter
MeSH Terms:
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/surgery
Humans ; Oxaliplatin/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Neoadjuvant Therapy
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
Autorzy:
Han H; Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Huang H; Department of Thoracic Surgery, People's Hospital of Dongxihu District, Wuhan, Hubei, China.
Chen AP; Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Tang Y; Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Huang X; Department of Thoracic Surgery, People's Hospital of Dongxihu District, Wuhan, Hubei, China.
Chen C; Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 04; Vol. 19 (4), pp. e0292726. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Neoplasms*/pathology
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Humans ; Prognosis ; Proportional Hazards Models ; Disease-Free Survival ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinicopathological characteristics of patients with primary tracheal tumors: Analysis of eighty-nine cases.
Autorzy:
Piórek A; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Płużański A; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Teterycz P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Computational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Tabor S; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Winiarczyk K; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Knetki-Wróblewska M; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Kowalski DM; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Krzakowski M; Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Apr; Vol. 15 (11), pp. 878-883. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Tracheal Neoplasms*/pathology
Carcinoma, Squamous Cell*/pathology
Carcinoma, Adenoid Cystic*
Humans ; Male ; Female ; Retrospective Studies ; Trachea/pathology ; Prognosis ; Disease-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.
Autorzy:
Lee KH; Department of Colorectal Surgery, Chungnam National University Hospital & College of Medicine, Daejeon, Korea.
Yang IJ; Department of Colorectal Surgery, Chungnam National University Hospital & College of Medicine, Daejeon, Korea.
Ha GW; Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju, Korea.
Lee J; Department of Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
Park YY; Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.
Lee SH; Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.
Lee JM; Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Bae JH; Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Park EJ; Division of Colorectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Kim H; Department of Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim KY; Department of General Surgery, Wonkwang University Hospital & School of Medicine, Iksan, Korea.
An S; Department of Surgery, Yonsei University, Wonju College of Medicine, Wonju, Korea.
Kim IY; Department of Surgery, Yonsei University, Wonju College of Medicine, Wonju, Korea.
Kim JY; Department of Colorectal Surgery, Chungnam National University Hospital & College of Medicine, Daejeon, Korea. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 29; Vol. 24 (1), pp. 397. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Colonic Neoplasms*/pathology
Adult ; Aged ; Humans ; Middle Aged ; Young Adult ; Chemotherapy, Adjuvant ; Clinical Trials, Phase II as Topic ; Disease-Free Survival ; Multicenter Studies as Topic ; Progression-Free Survival ; Randomized Controlled Trials as Topic ; Fluorouracil/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of a nomogram based on the clinicopathological and CT features to predict the survival of primary pulmonary lymphoepithelial carcinoma patients.
Autorzy:
Nie K; Department of Radiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241 Huai-Hai West Road, Shanghai, 200030, P. R. China.
Zhu L; Department of Radiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241 Huai-Hai West Road, Shanghai, 200030, P. R. China.
Zhang Y; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
Chen Y; Department of Radiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241 Huai-Hai West Road, Shanghai, 200030, P. R. China.
Parrington J; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
Yu H; Department of Radiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241 Huai-Hai West Road, Shanghai, 200030, P. R. China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Mar 29; Vol. 25 (1), pp. 144. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:
Journal Article
MeSH Terms:
Nomograms*
Carcinoma*
Humans ; Retrospective Studies ; Tomography, X-Ray Computed ; Disease-Free Survival ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Burkitt lymphoma: The effect of age, sex and delay to diagnosis on treatment completion and outcome of treatment in 934 Patients in Cameroon.
Autorzy:
Hesseling PB; Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Afungchwi GM; Department of Nursing and Midwifery, The University of Bamenda, Bamenda, Cameroon.
Njodzeka BW; Cameroon Baptist Convention Health Services, Bamenda, Cameroon.
Wharin P; Beryl Thyer Memorial Africa Trust, Burton Latimer, United Kingdom.
Kouya FN; Cameroon Baptist Convention Health Services, Bamenda, Cameroon.
Kruger M; Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 11; Vol. 19 (3), pp. e0299777. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Burkitt Lymphoma*/diagnosis
Burkitt Lymphoma*/drug therapy
Burkitt Lymphoma*/pathology
Child ; Humans ; Male ; Female ; Aged ; Cameroon ; Cyclophosphamide/therapeutic use ; Methotrexate/therapeutic use ; Disease-Free Survival ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic value and relapse pattern of HER2-low in hormone receptor-positive breast cancer.
Autorzy:
Wei T; Department of VIP Medical, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Kang Y; Department of Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Wang X; Department of VIP Medical, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yue J; Department of VIP Medical, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yuan P; Department of VIP Medical, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 550-558. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Female ; Prognosis ; Receptor, ErbB-2 ; Disease-Free Survival ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Autorzy:
Xiao JJ; Department of Thyroid-Breast-Vascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China.
Huang ML; Department of Thyroid-Breast-Vascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China.
Yan CJ; Department of Thyroid-Breast-Vascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China.
Ling R; Department of Thyroid-Breast-Vascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China.
Wei HL; Department of Thyroid-Breast-Vascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Feb 23; Vol. 46 (2), pp. 146-154.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/surgery
Breast Neoplasms*/metabolism
Humans ; Female ; Prognosis ; Extranodal Extension/pathology ; Receptors, Progesterone/metabolism ; Retrospective Studies ; Disease-Free Survival ; Estrogens/therapeutic use ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma.
Autorzy:
Jin Y; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University & National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.
Ren H; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University & National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.
Yue Q; Sichuan Academy of Chinese Medicine Sciences, Chengdu, 610000, China.
Wu W; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University & National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.
Liu C; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University & National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.
Guo Y; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University & National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China.
Zhao P; Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University & National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058, China. .; The First Affiliated Hospital, Zhejiang University School of Medicine & Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, 79 Qingchun Road, Hangzhou, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 23; Vol. 24 (1), pp. 258. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/therapy
Humans ; Progression-Free Survival ; Proportional Hazards Models ; Biomarkers ; Disease-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.
Autorzy:
Chen Z; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, China.; Department of Radiation Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan, China.
Liang Z; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, China.
Chen K; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, China.
Zhang S; Department of Radiation Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan, China.
Huang X; Department of Radiation Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan, China.
Wu G; Department of Radiation Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan, China.
Zhu X; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, China. .; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, 530199, Guangxi, China. .; Key Laboratory of Early Prevention and Treatment for Regional High-Incidence-Tumor, Guangxi Medical University, Ministry of Education, Nanning, 530021, Guangxi, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 21; Vol. 14 (1), pp. 4311. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma*/pathology
Nasopharyngeal Neoplasms*/pathology
Humans ; Nasopharyngeal Carcinoma/pathology ; Retrospective Studies ; Prognosis ; Ferritins ; Neoplasm Staging ; Disease-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
Autorzy:
Zhong ML; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Care Hospital, 330008, Nanchang, Jiangxi, China.
Liu YC; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Care Hospital, 330008, Nanchang, Jiangxi, China.
Yang JT; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Care Hospital, 330008, Nanchang, Jiangxi, China.
Wang YN; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Care Hospital, 330008, Nanchang, Jiangxi, China.
Ao MH; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Care Hospital, 330008, Nanchang, Jiangxi, China.
Xiao Y; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang Medical College, 330029, Nanchang, Jiangxi, China.
Zeng SY; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Care Hospital, 330008, Nanchang, Jiangxi, China.
Liang MR; Department of Gynecological Oncology, Jiangxi Maternal and Child Health Care Hospital, 330008, Nanchang, Jiangxi, China. .; Graduate School, Medical College of Nanchang University, No. 318, Bayi Avenue, 330006, Nanchang, Jiangxi, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 15; Vol. 24 (1), pp. 217. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/pathology
Female ; Child ; Humans ; Chemoradiotherapy/adverse effects ; Lymph Nodes/pathology ; Disease-Free Survival ; Lymph Node Excision ; Retrospective Studies ; Neoplasm Staging ; Hysterectomy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series.
Autorzy:
Gnoli M; Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Gambarotti M; Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Righi A; Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Staals EL; Department of Orthopaedic Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Evangelista A; General Affair Units, Italy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Tremosini M; Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Brizola E; Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Mordenti M; Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy. .
Boarini M; Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Locatelli M; Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Pedrini E; Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Sangiorgi L; Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 13; Vol. 19 (1), pp. 63. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Exostoses, Multiple Hereditary*/genetics
Chondrosarcoma*/genetics
Chondrosarcoma*/diagnosis
Chondrosarcoma*/pathology
Osteochondroma*/pathology
Bone Neoplasms*/genetics
Bone Neoplasms*/diagnosis
Bone Neoplasms*/pathology
Female ; Humans ; Male ; Adult ; Retrospective Studies ; Disease-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non-metastatic stage T4 nasopharyngeal carcinoma in IMRT era.
Autorzy:
Zheng Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Xue F; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Ou D; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Niu X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Hu C; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
He X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Shanghai, China.; Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e6578.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma*/drug therapy
Radiotherapy, Intensity-Modulated*/adverse effects
Nasopharyngeal Neoplasms*/pathology
Humans ; Nasopharyngeal Carcinoma/drug therapy ; Retrospective Studies ; Chemoradiotherapy/adverse effects ; Nausea/drug therapy ; Vomiting/drug therapy ; Disease-Free Survival ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 diffuse large B-cell lymphoma.
Autorzy:
Deng T; Department of Hematology, Chongqing Fifth People's Hospital, Chongqing, PR China.
Zhang S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Gu J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Zhou X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7005.
Typ publikacji:
Journal Article
MeSH Terms:
Myeloid Differentiation Factor 88*/genetics
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Piperidines*
Pyridines*
Humans ; Aged ; Rituximab/therapeutic use ; Disease-Free Survival ; Retrospective Studies ; Vincristine/adverse effects ; Cyclophosphamide/adverse effects ; Doxorubicin/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Prednisone/adverse effects ; CD79 Antigens/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic factors and benefit populations of ovarian function suppression in premenopausal HR+/HER2+ early-stage breast cancer patients who received trastuzumab: Evidence from a real-world study with long-term follow-up.
Autorzy:
Ju J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Gao SL; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), The VIPII Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital and Institute, Beijing, China.
Wang JY; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Sang D; Department of Medical Oncology, Beijing Sanhuan Cancer Hospital, Beijing, China.
Kang YK; Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Wang X; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yue J; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shuai Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qi YX; Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shi Jiazhuang, China.
Yuan P; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (6), pp. 439-447. Date of Electronic Publication: 2024 Jan 07.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Adult ; Female ; Trastuzumab/pharmacology ; Trastuzumab/therapeutic use ; Follow-Up Studies ; Prognosis ; Toremifene/therapeutic use ; Retrospective Studies ; Tamoxifen/therapeutic use ; Disease-Free Survival ; Chemotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.
Autorzy:
Ling Q; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Huang ST; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Yu TH; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Liu HL; West China School of Medicine, Sichuan University, Chengdu, China.
Zhao LY; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Chen XL; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Liu K; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Chen XZ; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Yang K; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Hu JK; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China. .; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. .
Zhang WH; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China. .; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2023 Dec 01; Vol. 21 (1), pp. 377. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/surgery
Humans ; Neoadjuvant Therapy/methods ; Retrospective Studies ; Disease-Free Survival ; Chemotherapy, Adjuvant/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy.
Autorzy:
Ma GF; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Lin GL; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. .
Wang ST; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Huang YY; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Xiamen Branch, Fujian, 361000, China.
Xiao CL; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Sun J; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Shi TY; Department of Gynecological Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Xiang LB; Department of Gynecological Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2024 Jan 31; Vol. 24 (1), pp. 81. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/pathology
Female ; Humans ; Radiotherapy, Adjuvant ; Treatment Outcome ; Disease-Free Survival ; Neoplasm Staging ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology ; Hysterectomy ; Lymph Node Excision
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 16810

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies